Reaction

Pleural Thickening reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 673 reports · 37 co-occurring drugs

As of the last recalculation, Pleural Thickening appears in 673 FAERS reports alongside 37 co-occurring drug terms. The strongest observed disproportionality signal is TRAZODONE HYDROCHLORIDE (PRR 159.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Trazodone Hydrochloride	72	159.3	160.0
Loperamide Hydrochloride Oral	44	142.5	143.1
Diphenoxylate Hydrochloride And Atropine Sulfate	56	137.8	138.4
Thiamine Hydrochloride	51	137.0	137.6
Mometasone Furoate	138	128.6	129.0
Loperamide Hcl	45	115.9	116.3
Risedronate Sodium	94	108.6	108.9
Ciclesonide	33	78.7	78.9
Ascorbic Acid	52	74.9	75.0
Biotin	66	72.4	72.6
Sulfasalazine	123	59.3	59.4
Celecoxib	148	44.3	44.3
Esomeprazole	77	43.2	43.3
Ribociclib	41	42.7	42.8
Fentanyl	112	42.0	42.0
Hydroxychloroquine Sulfate	102	40.6	40.7
Tocilizumab	119	39.0	39.0
Acetaminophen, Guaifenesin, And Phenylephrine Hydrochloride	149	36.7	36.7
Crizotinib	14	34.8	34.8
Fulvestrant	34	33.5	33.5
Loperamide Hydrochloride	44	32.5	32.5
Abatacept	118	31.7	31.8
Oxycodone And Acetaminophen Tablets	11	29.0	29.0
Fluticasone Furoate And Vilanterol Trifenatate	30	27.0	27.0
Leflunomide	78	25.9	26.0
Goserelin	11	25.7	25.8
Hydroxychloroquine	57	25.7	25.7
Zoledronic Acid	31	25.0	25.0
Oxycodone Hydrochloride	117	20.0	20.0
Letrozole Tablets	28	18.7	18.8
Umeclidinium	5	17.4	17.4
Pyrazinamide	5	16.6	16.6
Oxycodone And Acetaminophen	11	14.8	14.8
Alpelisib	4	14.3	14.3
Tofacitinib	72	13.4	13.4
Polatuzumab Vedotin	3	9.5	9.5
Osimertinib	8	7.8	7.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.